Zobrazeno 1 - 10
of 23
pro vyhledávání: '"A. O. J., AGBOOLA"'
Publikováno v:
Journal of Global Oncology
Purpose Triple-negative breast cancer (TNBC) is the most deadly form of breast cancer (BC) today. TNBC treatment is fraught with challenges because of the extensive interpatient heterogeneity in clinical behavior and scarcity of stratifying biomarker
Autor:
Wakkas Fadhil, Henry O Ebili, A O J Agboola, Abutaleb Asiri, Hersh A. Ham-Karim, James Hassall, Mohammad Ilyas
Publikováno v:
Journal of Clinical Pathology. 70:702-711
Aims We previously described the quick multiplex consensus PCR (QMC-PCR) as a method for rapid mutation screening in low-quality template. QMC-PCR has two-stages: a prediagnostic multiplex (PDM) reaction followed by a single specific diagnostic react
Autor:
Guanhao Wei, Remus Osan, Uma Krishnamurti, Andrew R. Green, Nikita Wright, A O J Agboola, Emad A. Rakha, Lauren E. McCullough, Ian O. Ellis, Padmashree C.G. Rida, Xiaoxian Li, Chaeyun Lee, Ritu Aneja, Bikram Sahoo
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:C026-C026
Triple-negative breast cancer (TNBC) disproportionately affects African-American (AA) women. Literature underscores that women from West Africa exhibit higher TNBC incidence and mortality rates than AA women. Distinctions in inherent tumor biology be
Publikováno v:
Journal Africain du Cancer / African Journal of Cancer. 7:178-185
Background The incidence rate of breast cancer (BC) in the high income countries (HIC) is higher than in low income countries (LIC) and middle income countries (MIC), but the overall mortality rate is much less than in LIC and MIC. Most cases of BC i
Autor:
C. C. Nolan, Andrew R. Green, A A Banjo, Ian O. Ellis, Emad A. Rakha, Henry Okuchukwu Ebili, BA Salami, A O J Agboola, Victoria O. Iyawe, Kikelomo Rachel Adeleke
Publikováno v:
Molecular diagnosistherapy. 22(1)
Checkpoint kinase 1 (CHEK1), a DNA damage sensor and cell death pathway stimulator, is regarded as an oncogene in tumours, where its activities are considered essential for tumourigenesis and the survival of cancer cells treated with chemotherapy and
Autor:
Teresa P Raposo, Mohammad Ilyas, Henry O Ebili, Wakkas Fadhil, A O J Agboola, Abutaleb Asiri, James Hassall, Hersh A. Ham-Karim
Currently, short DNA segments of sub-100 bp can be sequenced either directly by next-generation sequencing and pyrosequencing, which are expensive, or indirectly, via Sanger sequencing combined with the cumbersome and failure-prone plasmid cloning. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cb9e4681e3f3f4b59a2ccc3693b6bc5
https://europepmc.org/articles/PMC5460669/
https://europepmc.org/articles/PMC5460669/
Autor:
Emad A. Rakha, Henry Okuchukwu Ebili, Victoria O. Iyawe, A A Banjo, BA Salami, A O J Agboola, Andrew R. Green, Chrstopher C. Nolan, Ian O. Ellis
Ku 70/80 is a regulator of the Non-Homologous End Joining (NHEJ) roles in clinicopathological features, and has prognostic significance in breast cancer (BC) in Caucasian populations. However, its significance in the Nigerian BC population, which is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5106c32606165c47da713f668bc8f3d8
Publikováno v:
Journal Africain du Cancer / African Journal of Cancer. 6:79-84
Background Breast cancer is the commonest cause of cancer-related deaths in the world. There is paucity of data on breast cancer incidence, epidemiological features, treatment and survival in our environment and, thus, the aim of this study is to doc
Autor:
A A Musa, C. C. Nolan, Charles C. Anunobi, A A Banjo, Emad A. Rakha, M. Deji-Agboola, BA Salami, Ian O. Ellis, A O J Agboola, Andrew R. Green
Publikováno v:
Journal Africain du Cancer / African Journal of Cancer. 6:129-137
Objectif Cette etude examine le pronostic de l’inhibiteur de differenciation 4 (ID4) d’une proteine heliceboucle-helice, un regulateur negatif du gene 1 associe au cancer du sein (BRCA1) chez des femmes nigerianes atteintes d’un cancer du sein
Autor:
Tma Abdel-Fatah, Emad A. Rakha, C. C. Nolan, AM Deji-Agboola, A A Musa, BA Ayoade, A A Banjo, N. Wanangwa, Andrew R. Green, A O J Agboola, Ian O. Ellis, TY Oyebadejo
Publikováno v:
Breast Cancer Research and Treatment. 135:555-569
Although breast cancer (BC) incidence is lower in African-American women compared with White-American, in African countries such as Nigeria, BC is a common disease. Nigerian women have a higher risk for early-onset, with a high mortality rate from BC